Evidence map›Paper›PMID 23483200›Full record

ArticlePsychopharmacology2013

Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice.

Joyonna C Gamble-George, Jordan R Conger, Nolan D Hartley, Prerna Gupta, Joshua J Sumislawski, Sachin Patel

Open access · greenAbstract read
In one paragraph

Article in Psychopharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Hepatic targeting of the centrally active cannabinoid 1 receptor (CBJournal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  4. Motor-like Tics are Mediated by CBMolecular neurobiology · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
  11. Article
  12. Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Review
  13. Article
  14. Article
  15. Cannabinoid Modulation of the Stressed Hippocampus.Frontiers in molecular neuroscience · 2017
    Review
  16. Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive-Like Behavior During Forced Abstinence From Alcohol Drinking.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Article
  17. Article
  18. Neurobiological Interactions Between Stress and the Endocannabinoid System.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Joyonna C Gamble-GeorgeDepartment of Psychiatry, Vanderbilt University School of Medicine, Robinson Research Building, Rm 724B, Nashville, TN 37212, USA.
Jordan R Conger
Nolan D Hartley
Prerna Gupta
Joshua J Sumislawski
Sachin Patel
Vanderbilt University · US

Funding

Vanderbilt/Meharry Initiative for Minority Student DvptR25GM062459 · NIGMS · VANDERBILT UNIVERSITY · PI VELEZ EDWARDS, DIGNA R · 2002 to 2020
$10.4M
Stress adaptations in endocannabinoid signaling in the amygdalaK08MH090412 · NIMH · VANDERBILT UNIVERSITY · PI PATEL, SACHIN · 2010 to 2014
$842k
NIGMS NIH HHS R25 GM062459NIMH NIH HHS K08 MH090412NIMH NIH HHS MH090412
6 · The paper itself

Abstract

rationaleCentral CB1 cannabinoid receptors regulate anxiety-like and appetitive consummatory behaviors. Pharmacological antagonism/inverse-agonism of CB1 receptors increases anxiety and decreases appetitive behaviors; however, neither well-defined dose nor context dependence of these effects has been simultaneously assessed in one behavioral assay.

objectivesWe sought to determine the context and dose dependence of the effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in a model that allowed for simultaneous detection of anxiety-like and consummatory-related behaviors.

methodsWe determined the effects of the CB1 receptor antagonist/inverse-agonist, rimonabant, in the novelty-induced hypophagia (NIH) assay in juvenile male ICR mice.

resultsRimonabant dose-dependently decreased consumption of a palatable reward solution completely independent of contextual novelty. Grooming and scratching behavior was also increased by rimonabant in a context-independent manner. In contrast, rimonabant increased feeding latency, a measure of anxiety-like behaviors, only in a novel, mildly anxiogenic context. The effects of rimonabant were specific since no effects of rimonabant on despair-like behavior were observed in the tail suspension assay. Blockade of CB2 receptors had no effect on novelty-induced increases in feeding latency or palatable food consumption.

conclusionsOur findings indicate that CB1 receptor blockade decreases the hedonic value of palatable food irrespective of environmental novelty, whereas the anxiogenic-like effects are highly context-dependent. Blockade of CB2 receptors does not regulate either anxiety-like or consummatory behaviors in the NIH assay. These findings suggest that rimonabant modulates distinct and dissociable neural processes regulating anxiety and consummatory behavior to sculpt complex and context-dependent behavioral repertories.

Indexed as

AnimalsAnxietyCannabinoid Receptor AntagonistsConsummatory BehaviorDose-Response Relationship, DrugFeeding and Eating DisordersHindlimb SuspensionMaleMiceMice, Inbred ICRMotor ActivityPiperidinesPyrazolesReceptor, Cannabinoid, CB1RimonabantStress, PsychologicalCannabinoid Receptor AntagonistsPiperidinesPyrazolesReceptor, Cannabinoid, CB1Rimonabant

Identifiers

PMID23483200
PMCPMC3707973
OpenAlexW2130393390

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.